Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer
about
Lycorine Induces Apoptosis of A549 Cells via AMPK-Mammalian Target of Rapamycin (mTOR)-S6K Signaling Pathway.PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes.Therapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities.Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition.Immunotherapy and Targeted Therapy for Small Cell Lung Cancer: There Is Hope.CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib.Unraveling the genomic complexity of small cell lung cancer.The PI3K Pathway in Human Disease.Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies.Small-cell lung cancer: what we know, what we need to know and the path forward.PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy.Target engagement imaging of PARP inhibitors in small-cell lung cancer.Targeting DNA damage repair in small cell lung cancer and the biomarker landscape.Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer.Miltirone-induced apoptosis in cisplatin-resistant lung cancer cells through upregulation of p53 signaling pathways.
P2860
Q33648092-F10F72B9-19C7-4126-88CF-5D905166D112Q37661664-EA2C2200-52C6-4B16-AA73-CF2B4BCE5899Q38683171-24413648-FCA8-4105-AEAF-83FA010557E8Q38815964-B5BDED66-16FB-4AA0-A4EE-6A1184D47B69Q39393217-4C05FA9D-C61E-41DF-8DCC-7114C6CE5845Q41466400-AC70DED7-8D84-4C04-BD91-9582A94D726AQ42398708-8F9F9228-C749-47A5-AE02-39D746534FABQ46546002-A8C914F8-55EE-4167-B7DC-F312E09CD4D2Q47161308-8B40E8AD-B517-420D-BC22-27399F2111B8Q47595394-77CC5CAF-05E5-4E34-9E53-3E70E6780545Q47748552-FA0394B0-79AA-4CE0-B54C-AD75DC4B21B5Q48251246-A1FAEC32-6EA1-40E6-BC12-EDB2A515E55CQ52657032-A20C8B2B-6428-473F-89F3-AD18F3886142Q55211683-F7487794-8F72-4C70-9FCC-9238483D2FDFQ55347991-FDC673A3-0F2B-477A-B881-873FD976C32C
P2860
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer
@ast
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer
@en
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer
@nl
type
label
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer
@ast
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer
@en
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer
@nl
prefLabel
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer
@ast
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer
@en
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer
@nl
P2093
P2860
P3181
P1433
P1476
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer
@en
P2093
C Allison Stewart
Fatemeh Masrorpour
Lauren A Byers
Lixia Diao
Monique Nilsson
Robert J Cardnell
Seema Mukherjee
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0152584
P407
P577
2016-01-01T00:00:00Z